Skip to main content

Covid-19 treatment: Algeria to continue using Hydroxychloroquine

Algerian authorities have vowed they will not give up on the controversial use of hydroxychloroquine in the treatment against coronavirus, despite the decision of the World Health Organization (WHO) to suspend clinical trials, a member of the Pandemic Monitoring Committee said Tuesday.
“We have treated thousands of cases with this drug with great success to date. And we have not noted any adverse reactions,” Dr. Mohamed Bekkat, a member of the Scientific Committee monitoring the evolution of the Covid-19 pandemic in Algeria, told AFP.
“We have not recorded any deaths related to the use of (hydroxy)chloroquine,” said Dr. Bekkat, also president of the Council of the Algerian Medical Association. READ MORE

Comments

Popular posts from this blog

Russia displays its naval power

Russia's President Vladimir Putin (centre) walks with officials as he attends  a ceremony for Russia's Navy Day in Saint Petersburg on July 30, 2017 (AFP Photo/Alexey NIKOLSKY) President Vladimir Putin on Sunday oversaw a pomp-filled display of Russia's naval might as the Kremlin paraded its sea power from the Baltic Sea to the shores of Syria. Some 50 warships and submarines were on show along the Neva River and in the Gulf of Finland off the country's second city of Saint Petersburg after Putin ordered the navy to hold its first ever parade on such a grand scale. "Today much is being done to develop and modernise the navy," Putin told servicemen after surveying the military hardware from his presidential cutter. "The navy is not only dealing with its traditional tasks but also responding with merit to new challenges, making a significant contribution to the fight against terrorism and piracy." Read more

China getting serious with its science reputation, cracks down on fraudulent peer-review process

A massive peer-review fraud has triggered a tough response from the Chinese government. Officials last week announced that more than 400 researchers listed as authors on some 100 now-retracted papers will face disciplinary action because their misconduct has seriously damaged China’s scientific reputation. Some institutions have barred the scientists linked to the fraud from pursuing their research, at least temporarily. And they have imposed other penalties, including canceling promotions, honors, and grants. Government ministries have also announced new “zero tolerance” policies aimed at stamping out research fraud. "We should eradicate the problem from its roots," said He Defang, director of the Ministry of Science and Technology’s (MOST’s) regulatory division in Beijing. Although China has previously cracked down on scientific misconduct, a chronic problem. These penalties "are the harshest ever," says Chen Bikun, an information scientist at the Nanjing